![]() |
||||||||||||||||||||||||||||||||||
Immunocal
|
||||||||||||||||||||||||||||||||||
|
|||||||
A Simple Overview of the Immunocal Science |
|||||||
| The
Discovery of Immunocal: Dr. Bounous and his staff at the McGill University Immunology Department were investigating the differing effects of various protein food sources in the face of chemically induced colon cancer.
|
| Immunocal - For YOUR Immune
System! Patented with Anti-Cancer "Method of Use" Patents. With an effect so profound as "ANTI-CANCER" what else can this addition to your daily regimen do for you on a maintenance, prevention or treatment basis? |
|
| US
Patent Anti-cancer therapeutic compositions containing whey protein concentrate Patent #5,888,552 |
Canadian
Patent Anti-cancer therapeutic compositions for prophylaxis or for treatment of chemically induced cancer. Patent #2090377 |
Meet the Scientists behind ImmunotecBehind Immunotec and Immunocal are the world-renowned scientists Dr. Gustavo Bounous and Professor Wulf Dröge, who are highly respected around the world. Along with them is a team that ensures that Immunotec’s products are tested and proven to give you the benefits you want and need. |
![]() |
Dr. Gustavo BounousDr. Bounous developed the method for the production of undenatured whey protein which was given the proprietary name Immunocal. It became the standard by which all other whey products eventually had to be measured. Dr. Gustavo Bounous is the world renowned scientist who discovered Immunocal. Click
Here to Read More about Dr. Bounous.
|
![]() |
Dr. Wulf DrögeDr. Dröge was the first to describe the effect of glutathione on the immune response of a living organism (1986) and to discover the abnormally low cysteine and glutathione levels in HIV patients (1988/1989). In a series of clinical studies, Dr. Dröge investigated the effects of cysteine supplementation on the immune system in healthy humans and HIV patients and on weight loss in cachectic cancer patients. Presently, Dr. Dröge is actively engaged in the design of clinical studies and organizes research activities in cooperation with colleagues at McGill University and other leading scientific institutions. Dr. Dröge has devoted more than forty years to basic and clinical research that form the basis for the design of safe, effective new Immunotec products such as Immunocal Platinum. Dr. Droge is Immunotecs Senior Vice President of Research and Development Click Here to Read More about Dr. Droge. |
![]() |
Dr. Patricia A. L. Kongshavn Patricia Kongshavn received her Honors Degree in Natural Sciences as a Major Scholar at Cambridge University, and completed her doctorate in Immunology at McGill University after immigrating to Canada. She subsequently joined the Faculty of Medicine at McGill University and held appointments in the Departments of Physiology and Medicine, becoming Full Professor in 1986. Her research was funded by independent grants to her from the Medical Research Council of Canada, the National Cancer Institute of Canada and the National Institutes of Health in the United States. Her main research was concerned with increasing basic knowledge of the immune system, with a focus on cellular immunology, host/parasite interactions and the genetics of natural resistance. In the mid-1970’s she began collaboration initiated by Dr. Gustavo Bounous to research the influence of various dietary proteins on immune responsiveness. They published their first paper on this research in 1978 and continued their collaboration until 1989, during which period they co-authored 14 papers. This work led to the discovery of the undenatured whey protein concentrate that regulated glutathione levels and promoted immune enhancing activity. This led ultimately to the production of the high quality bioactive nutraceutical: IMMUNOCAL. |
Continue to
Immunocal Patents Page![]() |
|
